WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 22'6701 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 30'7221 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 49'003  48'733  48'454  48'165  47'868  45'977  42'972  37'451 
Births 470  468  465  462  458  540  670  813 
Surviving infants 469  466  463  460  456  537  662  789 
Pop. less than 5 years 2'349  2'310  2'237  2'217  2'192  3'129  3'241  3'836 
Pop. less than 15 years 7'519  7'704  7'870  8'088  8'304  9'636  11'014  12'703 
Female 15-49 years 12'812  12'879  12'948  12'993  13'035  13'153  12'282  9'885 

Number of reported case

(Click for retrospective incidence data for Republic of Korea (the))
Diphtheria 51 
Japanese encephalitis 20  26 
Measles 42  114  17  32'647  3'415  5'097 
Mumps 7'147  6'241  6'104  6'524  4'474  3'057 
Pertussis 230  97  18  42  28  174  1'554 
Polio* 14 
Rubella 27  53  21  37  31  153 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 17  19  14  17  14 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Republic of Korea (the))
Vaccine year result method % card seen                                                
BCG          100  99  96  96  96  73  72 
DTP1          100  100  96  96  95  97 
DTP3          100  99  94  94  94  97  74  70 
HepB_BD          95  95  94  93 
HepB3          99  99  94  94  94  93 
Hib3         
JapEnc          99  98  89  89  84 
MCV          99  99  98  93  92  95  93 
MCV2          97  98  98  100  100  39 
PCV1         
PCV3         
Pol3          99  98  95  95  92  99  74  89 
Rota1         
Rota_last         
Rubella1          99  99  98  93  92 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Republic of Korea (the))
BCG 99  99  96  96  96  73  72 
DTP1 99  99  96  96  95  97  90 
DTP3 99  99  94  94  94  97  74 
HepB3 99  99  94  94  94  93 
Hib3
MCV 99  99  98  93  92  95  93 
PCV3
Pol3 99  98  95  95  92  99  74 
Rota_last


Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-4 weeks; Yes
DTaP 2, 4, 6, 15-18 months; 4-6 years; Yes
DTaPIPV 2, 4, 6 months; 4-6 years; Yes
HFRS 1st contact, +1months; +1 year; Yes high risk group
HepB birth; 1, 6 months; Yes and adults
IPV 2, 4, 6 months; 4-6 years; Yes
Influenza Yes High Risk group
JapEnc 12-24 months; +1-4 weeks; +1 year; 6, 12 years; Yes
MMR 12-15 months; 4-6 years; Yes
Td 11-12 years; Yes
Tdap 11-12 years; Yes
Typhoid Yes high risk group
Varicella 12-15 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2008-2012  2008-2012  2008-2012  2008-2012  2008-1012    NA 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 254    230  270  270  251  251 
Nº districts with DTP3 coverage >=80% number     270  270  251  251 
% of districts with DTP3 coverage >=80% From 0 to 100%       100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%     48  48  NA  NA   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.